Effect of Magnesium on Severity of Pain and Spasticity

Effect of Magnesium on the Severity of Pain and Spasticity in Patients with Cerebral Palsy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190817044550N1

Enrollment

Registered

2020-02-01

Start date

2019-01-21

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral palsy.

Interventions

The intervention group consisted of 30 eligible patients and the intervention was administered daily for 100–300 mg magnesium sulfate daily for 6 weeks, but given that our statistical population was c

Eligibility

Sex/Gender

All

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: patients with spastic cerebral palsy children in the age of 2 to 17 years old

Exclusion criteria

Exclusion criteria: Botox injection for at least 6 months The use of muscle relaxant drugs

Design outcomes

Primary

Measure	Time frame
Faces Pain Scale scores. Timepoint: 6 months after patients entered to the study. Method of measurement: FPS test.;Modified Ashworth scale scores. Timepoint: 6 months after patients entered to the study. Method of measurement: MAS test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Shajari

Islamic Azad University

a_shajari@iauyazd.ac.ir+98 35 3187 2200

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026